Impact of Arteriovenous fistula creation on estimated glomerular filtration rate decline in Predialysis patients

BMC Nephrology

Table 1 Baseline characteristics

Variable	n = 146
Age (years)	69 (61–75)
Female sex	67 (46)
BMI^a	30 (27–34)
eGFR (mL/min/1.73 m²)
First eGFR during study period	18 (15–22)
eGFR at AVF creation	13 (11–14)
Race
Black	7 (5)
White	128 (88)
Other	11 (8)
Comorbidities
Hypertension	142 (97)
Diabetes	89 (61)
Cardiovascular disease	67 (46)
Chronic obstructive pulmonary disease	24 (16)
Heart failure	9 (6)
Active smoking	24 (16)
Primary kidney disease^b
Benign nephrosclerosis	54 (38)
Diabetic nephropathy	51 (35)
Glomerulonephritis	25 (17)
Others	14 (10)
Furosemide use pre-AVF	103 (70)
RAAS blockade use pre-AVF	111 (76)
Patients with ≥1 hospitalisation pre-AVF	56 (38)

Results are presented as number (proportion) or median (interquartile range)
BMI Body mass index, eGFR estimated glomerular filtration rate, AVF arteriovenous fistula, RAAS Renin angiotensin aldosterone system
^aBMI, n = 108; ^b primary kidney disease, n = 144;

ISSN: 1471-2369